$29.41
2.08% day before yesterday
NYSE, Aug 22, 10:14 pm CET
ISIN
US15135B1017
Symbol
CNC

Centene Stock price

$29.41
+1.52 5.45% 1M
-29.52 50.09% 6M
-31.17 51.45% YTD
-48.82 62.41% 1Y
-67.39 69.62% 3Y
-30.87 51.21% 5Y
-1.01 3.30% 10Y
+22.13 303.98% 20Y
NYSE, Closing price Fri, Aug 22 2025
+0.60 2.08%

Key metrics

Basic
Market capitalization
$14.4b
Enterprise Value
$14.7b
Net debt
$296.0m
Cash
$17.3b
Shares outstanding
491.1m
Valuation (TTM | estimate)
P/E
7.1 | 5.4
P/S
0.1 | 0.1
EV/Sales
0.1 | 0.1
EV/FCF
13.6
P/B
0.5
Financial Health
Equity Ratio
32.0%
Return on Equity
12.5%
ROCE
4.0%
ROIC
4.6%
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$178.2b | $186.3b
EBITDA
$3.2b | $2.1b
EBIT
$2.0b | $526.8m
Net Income
$2.1b | $2.7b
Free Cash Flow
$1.1b
Growth (TTM | estimate)
Revenue
13.0% | 14.3%
EBITDA
-32.8% | -54.2%
EBIT
-44.4% | -84.0%
Net Income
-27.2% | -18.3%
Free Cash Flow
-51.2%
Margin (TTM | estimate)
Gross
8.9%
EBITDA
1.8% | 1.1%
EBIT
1.1%
Net
1.2% | 1.5%
Free Cash Flow
0.6%
More
EPS
$4.2
FCF per Share
$2.2
Short interest
6.5%
Employees
61k
Rev per Employee
$2.7m
Show more

Is Centene a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Centene Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a Centene forecast:

7x Buy
28%
17x Hold
68%
1x Sell
4%

Analyst Opinions

25 Analysts have issued a Centene forecast:

Buy
28%
Hold
68%
Sell
4%

Financial data from Centene

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
178,190 178,190
13% 13%
100%
- Direct Costs 162,286 162,286
16% 16%
91%
15,904 15,904
8% 8%
9%
- Selling and Administrative Expenses 12,661 12,661
2% 2%
7%
- Research and Development Expense - -
-
-
3,243 3,243
33% 33%
2%
- Depreciation and Amortization 1,256 1,256
0% 0%
1%
EBIT (Operating Income) EBIT 1,987 1,987
44% 44%
1%
Net Profit 2,054 2,054
27% 27%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Centene directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Centene Stock News

Neutral
GlobeNewsWire
2 days ago
SAN FRANCISCO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- A securities class-action lawsuit has been filed against Centene Corporation (NYSE: CNC), a major provider of healthcare services. The lawsuit, captioned Lunstrum v.
Neutral
GlobeNewsWire
2 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options
Neutral
PRNewsWire
3 days ago
NEW YORK , Aug. 21, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the "Class Period"), of the important September 8, 2025 lead plaintiff deadline. So what: If you purchased Centene securities during the Class Period you may be enti...
More Centene News

Company Profile

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Head office United States
CEO Sarah London
Employees 60,500
Founded 1984
Website www.centene.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today